649 filings
Page 9 of 33
EFFECT
yspymdej
10 Dec 18
Notice of effectiveness
12:16am
CORRESP
2he8f95 ibc9
4 Dec 18
Correspondence with SEC
12:00am
UPLOAD
cuq5nul2lkyxd0
4 Dec 18
Letter from SEC
12:00am
S-8
17ju qxihe
7 Nov 18
Registration of securities for employees
4:57pm
8-K
wu3dg8r9wq51awg
7 Nov 18
Achieve Reports Financial Results for Third Quarter 2018 and Provides Cytisinicline (Cytisine) Clinical Development Update
12:00am
8-K
uqooe0fx5so
1 Oct 18
Achieve Announces Pricing of $5.6 Million Registered Direct Offering
5:11pm
424B5
yr32fu7
1 Oct 18
Prospectus supplement for primary offering
5:04pm
8-K
2guryuakd9
28 Sep 18
Achieve Announces Results of Clinical Study Demonstrating Similar Bioavailability for a New Cytisine Formulation in Fed and Fasted Subjects
5:27pm
8-K
adbtftqljsdbn 8q
21 Sep 18
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
0gl4i
8 Aug 18
Achieve Reports Financial Results for Second Quarter 2018 and Provides Cytisine Clinical Development Update
4:10pm
8-K
z1gii6ebiloet3
20 Jun 18
Achieve Life Sciences Announces Pricing of $12 Million Underwritten Public Offering
8:45am
424B4
oy2pl75tjd fy22
15 Jun 18
Prospectus supplement with pricing info
5:24pm
S-1MEF
t5xgou9kijkkxyrn0
14 Jun 18
Registration of additional securities for an S-1
12:00am
EFFECT
vo5lu
14 Jun 18
Notice of effectiveness
12:00am
CORRESP
a631tm
13 Jun 18
Correspondence with SEC
12:00am